secwatch / observer
8-K filed August 16, 2024, 7:59 PM ET ticker ATER CIK 0001757715
other confidence high sentiment neutral materiality 0.30

Aterian engages advisor William Kurtz at $8,750/month; elects Lattmann as director

Aterian, Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001437749-24-027096
form_type
8-K
ticker
ATER
cik
0001757715
company_name
Aterian, Inc.
filed_at
2024-08-16T23:59:59+00:00
discovered_at
2026-05-14T18:03:14.427469+00:00
generated_at
2026-05-31T08:52:21.271118+00:00
sec_items
["5.02", "5.07", "9.01"]
event_type
other
sentiment
neutral
materiality_score
0.3
calibrated_materiality_score
0.3
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001437749-24-027096
json_url
https://secwatch.observer/filing/0001437749-24-027096.json
markdown_url
https://secwatch.observer/filing/0001437749-24-027096.md
text_url
https://secwatch.observer/filing/0001437749-24-027096.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1757715/000143774924027096/0001437749-24-027096-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1757715/000143774924027096/ater20240816_8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

William Kurtz

advisor to senior management
ATER · Aterian, Inc.
Effective
2024-08-01
Filed
August 16, 2024, 7:59 PM ET
Mr. William Kurtz and the Company entered into an Advisor Agreement effective August 1, 2024 (the “Advisor Agreement”), pursuant to which Mr. Kurtz shall act as an advisor to senior management of the Company.

Source-grounded claims

a5de0806f5

William Kurtz was appointed as advisor to senior management at Aterian, Inc..

Mr. William Kurtz and the Company entered into an Advisor Agreement effective August 1, 2024 (the “Advisor Agreement”), pursuant to which Mr. Kurtz shall act as an advisor to senior management of the Company.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Comparable filings

HAFC

Director Gideon Yu resigns from Hanmi board; stockholders approve 2026 ESPP

HANMI FINANCIAL CORP May 27, 2026, 6:15 PM ET other Items 5.02, 5.07, 9.01

same fact type: executive_change same SEC item: 5.02, 5.07, 9.01 same event type: other similar materiality

This filing

Mr. William Kurtz and the Company entered into an Advisor Agreement effective August 1, 2024 (the “Advisor Agreement”), pursuant to which Mr. Kurtz shall act as an advisor to senior management of the Company.

Comparable filing

On May 22, 2026, Gideon Yu, a member of the Board of Directors of Hanmi Financial Corporation (the 'Corporation') and its subsidiary corporation, Hanmi Bank (the 'Bank'), notified the Corporation of his resignation from the Boards of the Corporation and the Bank, effective immediately.

Filing page SEC filing

TKNO

Alpha Teknova director Irene Davis to retire; board reduced from 8 to 7; shareholder votes approved nominees and auditor

Alpha Teknova, Inc. June 1, 2026, 5:22 PM ET leadership Items 5.02, 5.07, 9.01

same fact type: executive_change same SEC item: 5.02, 5.07, 9.01 similar materiality

This filing

Mr. William Kurtz and the Company entered into an Advisor Agreement effective August 1, 2024 (the “Advisor Agreement”), pursuant to which Mr. Kurtz shall act as an advisor to senior management of the Company.

Comparable filing

On May 27, 2026, Irene Davis, a member of the Board of Directors (the “Board”) of Alpha Teknova, Inc. (the “Company”) and a member of the Nominating and Corporate Governance Committee, notified the Company of her intention not to stand for re-election to the Board at the Company’s 2026 Annual Meeting of Stockholders (the “Meeting”) and to retire from the Board and all committees thereof, effective upon the date of the Meeting.

Filing page SEC filing

SYRE

Spyre Therapeutics stockholders approve amended ESPP; director Peter Harwin resigns

Spyre Therapeutics, Inc. May 29, 2026, 4:45 PM ET other_material Items 5.02, 5.07, 9.01

same fact type: executive_change same SEC item: 5.02, 5.07, 9.01 similar materiality

This filing

Mr. William Kurtz and the Company entered into an Advisor Agreement effective August 1, 2024 (the “Advisor Agreement”), pursuant to which Mr. Kurtz shall act as an advisor to senior management of the Company.

Comparable filing

In addition, effective as of May 27, 2026, Peter Harwin resigned from the Board.

Filing page SEC filing

FIBK

First Interstate BancSystem: three directors retire per age policy; charter amended to plurality voting

FIRST INTERSTATE BANCSYSTEM INC May 29, 2026, 4:26 PM ET leadership Items 5.02, 5.03, 5.07, 9.01

same fact type: executive_change same SEC item: 5.02, 5.07, 9.01 similar materiality

This filing

Mr. William Kurtz and the Company entered into an Advisor Agreement effective August 1, 2024 (the “Advisor Agreement”), pursuant to which Mr. Kurtz shall act as an advisor to senior management of the Company.

Comparable filing

on May 27, 2026, each of Ms. Patricia L. Moss and Messrs. David L. Jahnke and Stephen M. Lacy, each having reached the retirement age of 72, was deemed to have retired and resigned automatically from the Company’s Board of Directors

Filing page SEC filing

JOB

Darla Moore resigns from GEE Group board effective June 1, 2026, due to other commitments

GEE Group Inc. June 1, 2026, 4:47 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 similar materiality

This filing

Mr. William Kurtz and the Company entered into an Advisor Agreement effective August 1, 2024 (the “Advisor Agreement”), pursuant to which Mr. Kurtz shall act as an advisor to senior management of the Company.

Comparable filing

On June 1, 2026, GEE Group Inc. (the “Company”) (NYSE American: JOB) issued a press release announcing that Ms. Darla Moore, has resigned as a member of the Board of Directors (the “Board”) and from all committees of the Company’s Board effective June 1, 2026, due to the time requirements necessary for her existing and new business commitments.

Filing page SEC filing

SERA

Sera Prognostics director Jeff Elliott resigns ahead of annual meeting

SERA PROGNOSTICS, INC. June 1, 2026, 4:44 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 similar materiality

This filing

Mr. William Kurtz and the Company entered into an Advisor Agreement effective August 1, 2024 (the “Advisor Agreement”), pursuant to which Mr. Kurtz shall act as an advisor to senior management of the Company.

Comparable filing

Jeffrey T. Elliott, a member of the Board of Directors (the “Board”) of Sera Prognostics, Inc. (the “Company”), notified the Company of his decision to resign from the Board effective as of June 4, 2026

Filing page SEC filing

FTI

TechnipFMC appoints Eric D. Mullins to Board of Directors effective June 1, 2026

TechnipFMC plc June 1, 2026, 4:38 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 similar materiality

This filing

Mr. William Kurtz and the Company entered into an Advisor Agreement effective August 1, 2024 (the “Advisor Agreement”), pursuant to which Mr. Kurtz shall act as an advisor to senior management of the Company.

Comparable filing

the Board elected Eric Mullins to the Board and appointed Mr. Mullins to the Audit Committee of the Board, effective June 1, 2026.

Filing page SEC filing

MED

Medifast Chief Legal Officer resigns; receives one-month severance of $35,648

MEDIFAST INC June 1, 2026, 8:59 AM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 similar materiality

This filing

Mr. William Kurtz and the Company entered into an Advisor Agreement effective August 1, 2024 (the “Advisor Agreement”), pursuant to which Mr. Kurtz shall act as an advisor to senior management of the Company.

Comparable filing

Effective as of May 29, 2026, Jason L. Groves, Esq., the Chief Legal Officer & Corporate Secretary of Medifast, Inc. (the “Company”), tendered his resignation from the Company.

Filing page SEC filing

Source: SEC EDGAR
accession 0001437749-24-027096

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.